Itolizumab is a breakthrough drug; Its Phase-IV trail will be conducted soon: Kiran Mazumdar Shaw, Biocon - Zee Business

Itolizumab is a breakthrough drug; Its Phase-IV trail will be conducted soon: Kiran Mazumdar Shaw, Biocon  Zee Business

Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases